The guideline incorporates the latest advice on diagnosis and treatment, lowering proteinuria targets, and integrating new agents such as nefecon, sparsentan, and SGLT2 inhibitors.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/kdigo-issues-new-guideline-managing-igan-and-igav-2025a1000qsr?src=rss
Author :
Publish date : 2025-10-06 11:46:00
Copyright for syndicated content belongs to the linked Source.
